Envoy Medical, Inc. cash flow to debt ratio of -1.98K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Envoy Medical, Inc.'s free cash flow has increased -2.90% from $-18.93M last year to $-18.38M, signaling increasing performance

Envoy Medical, Inc.'s debt to equity ratio is 0.08, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Envoy Medical, Inc.'s debt has increased relative to shareholder equity from -1.04 last year to 0.08 today, signaling weakened financials

Envoy Medical, Inc. has negative EBITDA, making leverage ratio unreliable

Envoy Medical, Inc.'s interest coverage ratio is -21.12, which means that the company struggles to meet interest obligations, signaling financial risk.

Envoy Medical, Inc.'s profit margin has decreased (6.85%) in the last year from -9.24K% to -9.88K%, signaling decreasing performance

Envoy Medical, Inc.'s short-term liabilities of $11.56M exceed its short-term assets of $6.28M, signaling financial risk

Envoy Medical, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Envoy Medical, Inc.'s return on equity of 239.44%, is higher than 15.00%, indicating good performance

Envoy Medical, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Envoy Medical, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Envoy Medical, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Envoy Medical, Inc. has negative free cash flow, indicating cash burn

Envoy Medical, Inc.'s yearly earnings has decreased 14.24% since last year from $-20.80M to $-23.76M, signaling decreasing performance

Envoy Medical, Inc.'s yearly revenue has increased 7.11% since last year from $225.00K to $241.00K, signaling increasing performance

ROIC -129.98% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Envoy Medical, Inc.'s 3-year revenue CAGR of 0.56% is positive, indicating growing revenue over the past 3 years

Envoy Medical, Inc. had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

Envoy Medical, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Envoy Medical, Inc. has insufficient data to evaluate this check.

Envoy Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Envoy Medical, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Envoy Medical, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Envoy Medical, Inc. has insufficient data to evaluate this check.

Envoy Medical, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Envoy Medical, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Envoy Medical, Inc. has a price-to-sales ratio of 223.15x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue